[PBS News Hour] New Hepatitis-C drug raises hope at a hefty price

Apr 23, 2014

JUDY WOODRUFF

April 23, 2014

JUDY WOODRUFF: Now: Who should pay when drugs are very effective, but extremely expensive?

That’s an important question for the U.S. health care system as new treatments come along, and it’s a matter of real concern over a new drug that has a 90 percent to 100 percent chance of curing the hepatitis C virus. Its manufacturer announced record sales yesterday of more than $2 billion in just the first quarter of the year. Profits, coverage and costs are all at issue, as Hari Sreenivasan reports.

[button title=”Read More” link=”http://www.pbs.org/newshour/bb/new-hepatitis-c-drug-raises-hope-hefty-price/?utm_campaign=KHN%3A+Daily+Health+Policy+Report&utm_source=hs_email&utm_medium=email&utm_content=12590123&_hsenc=p2ANqtz-8QBiWZv8aTxoWmNpts6Bv5gkCquRgEq8mU6jDWnuLEUBfRN71zE-mWZvXWU” target=”_blank” size=”” color=”” class=””]